Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 57 homolog (ZFP57) is a member of the KRAB-containing C2H2-type zinc finger protein family that acts as a sequence-specific DNA-binding transcriptional repressor. It plays a crucial role in the establishment and maintenance of genomic imprinting, primarily by recognizing methylated CpG dinucleotides at specific hexamer motifs, notably within imprinting control regions. ZFP57 recruits the KAP1 co-repressor complex to these sites, which leads to the establishment and maintenance of repressive chromatin marks—specifically H3K9me3—thus maintaining parental-origin-specific DNA methylation patterns during early development. Mutations in ZFP57 disrupt these processes and are associated with transient neonatal diabetes mellitus and multi-locus imprinting disturbances. While ZFP57 is essential for imprint maintenance in mice, in humans, it works in coordination with other KRAB zinc finger proteins, such as ZNF445.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 57 homolog (ZFP57).